Comparison of COVID-19 Vaccine Approvals at the US Food and Drug Administration, European Medicines Agency, and Health Canada

This qualitative improvement study investigates COVID-19 vaccine approvals at 3 medicine regulatory agencies in the US, EU, and Canada, characterizing and contrasting regulatory review times, and analyzing the clinical evidence supporting authorization.

Detalles Bibliográficos
Autores principales: Lythgoe, Mark P., Middleton, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233699/
https://www.ncbi.nlm.nih.gov/pubmed/34170306
http://dx.doi.org/10.1001/jamanetworkopen.2021.14531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233699/
https://www.ncbi.nlm.nih.gov/pubmed/34170306
http://dx.doi.org/10.1001/jamanetworkopen.2021.14531

Ejemplares similares